2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$4.48+$0.09 (+2.05%)
Price as of Aug 03, 2026 7:34 PM EDT- $298.6MMarket Cap
- 419.04%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$4.48+$0.09 (+2.05%)
Earnings Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 14.99% | ||
12-Month Momentum | 492.78% | ||
3-Month Risk Adjusted Momentum | 36.91% | ||
12-Month Risk Adjusted Momentum | 248.95% |
True Yield
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |